These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21993571)

  • 61. Magnesium-sensitive upstream ORF controls PRL phosphatase expression to mediate energy metabolism.
    Hardy S; Kostantin E; Wang SJ; Hristova T; Galicia-Vázquez G; Baranov PV; Pelletier J; Tremblay ML
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):2925-2934. PubMed ID: 30718434
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pentamidine is an inhibitor of PRL phosphatases with anticancer activity.
    Pathak MK; Dhawan D; Lindner DJ; Borden EC; Farver C; Yi T
    Mol Cancer Ther; 2002 Dec; 1(14):1255-64. PubMed ID: 12516958
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Developmental expression of the murine Prl-1 protein tyrosine phosphatase gene.
    Rundle CH; Kappen C
    J Exp Zool; 1999 May; 283(6):612-7. PubMed ID: 10194868
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3).
    Rivas DR; Dela Cerna MVC; Smith CN; Sampathi S; Patty BG; Lee D; Blackburn JS
    Sci Rep; 2021 May; 11(1):10302. PubMed ID: 33986418
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drosophila PRL-1 is a growth inhibitor that counteracts the function of the Src oncogene.
    Pagarigan KT; Bunn BW; Goodchild J; Rahe TK; Weis JF; Saucedo LJ
    PLoS One; 2013; 8(4):e61084. PubMed ID: 23577193
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mechanism of thienopyridone and iminothienopyridinedione inhibition of protein phosphatases.
    Zhang Z; Kozlov G; Chen YS; Gehring K
    Medchemcomm; 2019 May; 10(5):791-799. PubMed ID: 31191869
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cellular localization of PRL-1 and PRL-2 gene expression in normal adult human tissues.
    Dumaual CM; Sandusky GE; Crowell PL; Randall SK
    J Histochem Cytochem; 2006 Dec; 54(12):1401-12. PubMed ID: 16957164
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity.
    Gehring K; Miki H
    Br J Cancer; 2021 Mar; 124(6):1035-1036. PubMed ID: 33268817
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of proteins suppressing the functions of oncogenic phosphatase of regenerating liver 1 and 3.
    Lee JD; Jung H; Min SH
    Exp Ther Med; 2016 Nov; 12(5):2974-2982. PubMed ID: 27882103
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vivo analysis of lung cancer metabolism: nothing like the real thing.
    Hensley CT; DeBerardinis RJ
    J Clin Invest; 2015 Feb; 125(2):495-7. PubMed ID: 25607834
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tissue-specific alterations of PRL-1 and PRL-2 expression in cancer.
    Dumaual CM; Sandusky GE; Soo HW; Werner SR; Crowell PL; Randall SK
    Am J Transl Res; 2012; 4(1):83-101. PubMed ID: 22347524
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mutational Analysis of a Conserved Glutamate Reveals Unique Mechanistic and Structural Features of the Phosphatase PRL-3.
    Hoeger B; Rios P; Berteotti A; Hoermann B; Duan G; Köhn M
    ACS Omega; 2017 Dec; 2(12):9171-9180. PubMed ID: 30023603
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Overexpression of PTP4A1 is associated with poor overall survival in non-small cell lung cancer.
    Wang T; Shi X; Wang Z; Liu X; Zhang G; Zhu Q; Mi L; Wang R
    Int J Clin Exp Pathol; 2018; 11(7):3583-3590. PubMed ID: 31949737
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
    Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
    Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia.
    Park JE; Yuen HF; Zhou JB; Al-Aidaroos AQ; Guo K; Valk PJ; Zhang SD; Chng WJ; Hong CW; Mills K; Zeng Q
    EMBO Mol Med; 2013 Sep; 5(9):1351-66. PubMed ID: 23929599
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Altered expression of phosphatase of regenerating liver gene family in non-small cell lung cancer.
    Hwang JJ; Min SH; Sin KH; Heo YS; Kim KD; Yoo OJ; Lee SH
    Oncol Rep; 2012 Feb; 27(2):535-40. PubMed ID: 21993571
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Down-regulation of the human PRL-3 gene is associated with the metastasis of primary non-small cell lung cancer.
    Yamashita S; Masuda Y; Matsumoto K; Okumura Y; Matsuzaki H; Kurizaki T; Haga Y; Katafuchi S; Murayama T; Ikei S; Kawahara K
    Ann Thorac Cardiovasc Surg; 2007 Aug; 13(4):236-9. PubMed ID: 17717498
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Expression of phosphatase of regenerating liver-3 in gastric cancer, its relationship with prognosis, and its role in gastric cancer cell proliferation].
    Cai SR; Chen CQ; Wang Z; He YL; Cui J; Wu WH; Wu H; Zhan WH
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2326-30. PubMed ID: 19087692
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
    Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
    Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PRL PTPs: mediators and markers of cancer progression.
    Bessette DC; Qiu D; Pallen CJ
    Cancer Metastasis Rev; 2008 Jun; 27(2):231-52. PubMed ID: 18224294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.